Quick Order Cart

Cat. No. ARG1589

MRS2 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The MRS2 Knockout Raji Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population of human Raji B lymphocytes, engineered to disrupt the MRS2 gene encoding a mitochondrial magnesium transporter critical for ATP synthesis, oxidative phosphorylation, and regulation of apoptosis. This model impairs mitochondrial Mg2+ uptake, allowing researchers to study magnesium homeostasis, mitochondrial dysfunction, and cancer metabolism. It is compatible with a range of assays including Western blotting, apoptosis detection, and metabolic flux analysis, providing a versatile tool for elucidating the roles of MRS2 and interacting channels such as VDAC and MCU.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    MRS2

    Gene Identifier

    NCBI Gene ID 57380

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The MRS2 Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from human Raji B lymphocytes, designed to disrupt MRS2 gene function. This heterogeneous loss-of-function model enables robust investigation of mitochondrial magnesium transport without clonal selection bias, providing a valuable tool for functional genomics and drug screening studies.

Raji cells are a human Burkitt’s lymphoma B-cell line that retains key features of mature B lymphocytes, including antibody production and antigen presentation. Widely used in immunology and cancer research, their rapid growth and genetic tractability make them an excellent host for CRISPR-mediated gene disruption, especially for studying links between mitochondrial metabolism and B-cell malignancies.

MRS2 encodes a mitochondrial inner membrane magnesium channel that mediates matrix Mg2+ uptake, regulated by cytoplasmic magnesium levels and mitochondrial biogenesis signals. MRS2 interacts with the mitochondrial protein import machinery and Mg2+-binding proteins, and its activity is critical for ATP synthesis, oxidative phosphorylation, and apoptosis suppression. It functionally cooperates with VDAC and MCU to maintain mitochondrial cation homeostasis and energy metabolism.

In Raji cells, MRS2 knockout impairs mitochondrial Mg2+ accumulation, leading to reduced respiratory capacity, heightened apoptosis sensitivity, and metabolic reprogramming??hallmarks of magnesium deficiency and mitochondrial dysfunction. This model is particularly pertinent to cancer metabolism research, as lymphomas often rely on robust mitochondrial function for growth, and targeting magnesium homeostasis may expose therapeutic vulnerabilities.

These polyclonal knockout cells are ideal for studying magnesium homeostasis, mitochondrial transporter function, and cancer metabolism. Researchers can use Western blotting and RT-qPCR to verify MRS2 disruption, immunofluorescence for mitochondrial morphology, and cation-sensitive dyes to measure Mg2+ and Ca2+ fluxes. Functional readouts include Annexin V assays for apoptosis, ATP-level measurements, and metabolic flux analysis. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)